Synthetic biology has been plagued with exceptionally brisk progress in the recent years. The numerous processes and tools in synthetic biology advancing at an unprecedented rate. Our capabilities in bioengineering have grown, not just in the application of principles, but also the way we address and relate it to real life situations.
A recent report published by Dr. Christian R. Boehm and Dr. Bonnie Wintle, leading a team of experts from the Centre for the Study of Existential Risk, from the University of Cambridge. The report, published in an open journal called eLife, summarizes on a number of issues and segments of the field of synthetic biology.
The study discusses the challenges and the risks that the industry is likely to face in the coming years, particularly in the field of artificial and enhanced photosynthesis, synthetic gene drives, human genome editing and some fields that hold promise and potential in the future- that is microbiome based therapies, regenerative medicine, and bio-automation crossing paths with information security.
Johnathan Napier, a professor from Rothamsted Research also addressees the fact that the various challenges part of the Sustainable Development Goals are in dire need of innovation. He says that in the field of agriculture, the humankind is ‘on the cusp of new paradigms for how and what we grow, and where’.
Boehm says, as a conclusion that as different technologies come into existence, the matter of public trust and acceptance must also be taken into consideration.